Feasibility of genotyping melanocytic lesions by microsampling - 09/05/15
Jean-Marie Tan, MBBCh, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Lynlee L. Lin, ScD, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Duncan Lambie, MBBS, IQ Pathology, Brisbane, Queensland, Australia; Natalie Ong, MBBS, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Ross Flewell-Smith, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Kasturee Jagirdar, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Helmut Schaider, MD, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Richard A. Sturm, PhD, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; Tarl W. Prow, PhD, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia; H. Peter Soyer, MD, Dermatology Research Center, The University of Queensland, School of Medicine, Brisbane, Queensland, Australia
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 72 - N° 5S1
P. AB168 - mai 2015 Retour au numéro
Article précédent
- Epidemiologic study and survival analysis of head and neck melanoma: A 17-year study in Málaga, Spain
- From detection to communication: The patient perspective on the new diagnosis of melanoma
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?